[{"orgOrder":0,"company":"HoHo Biotech","sponsor":"Tri-Service General Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"TAIWAN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Hydrogen","moa":"None","graph1":"Immunology","graph2":"Phase I","graph3":"HoHo Biotech","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"HoHo Biotech \/ Tri-Service General Hospital","highestDevelopmentStatusID":"6","companyTruncated":"HoHo Biotech \/ Tri-Service General Hospital"},{"orgOrder":0,"company":"HoHo Biotech","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"TAIWAN","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Hydrogen","moa":"None","graph1":"Immunology","graph2":"Phase I","graph3":"HoHo Biotech","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"HoHo Biotech \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"HoHo Biotech \/ Undisclosed"},{"orgOrder":0,"company":"HoHo Biotech","sponsor":"Taoyuan Armed Forces General Hospital | Tri-Service General Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"TAIWAN","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Hydrogen","moa":"None","graph1":"Undisclosed","graph2":"Phase II","graph3":"HoHo Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"HoHo Biotech \/ Taoyuan Armed Forces General Hospital | Tri-Service General Hospital","highestDevelopmentStatusID":"8","companyTruncated":"HoHo Biotech \/ Taoyuan Armed Forces General Hospital | Tri-Service General Hospital"},{"orgOrder":0,"company":"H2 Global Group","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"CZECH REPUBLIC","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Hydrogen","moa":"Undisclosed","graph1":"Neurology","graph2":"IND Enabling","graph3":"H2 Global Group","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Inhalation","sponsorNew":"H2 Global Group \/ Undisclosed","highestDevelopmentStatusID":"5","companyTruncated":"H2 Global Group \/ Undisclosed"}]